Lipoprotein apheresis efficacy, challenges and outcomes: A descriptive analysis from the UK Lipoprotein Apheresis Registry, 1989-2017.

Pottle, Alison; Thompson, Gilbert; Barbir, Mahmoud; Bayly, Graham; Cegla, Jaimini; Cramb, Robert; Dawson, Tina; Eatough, Ruth; Kale, Vaishali; Neuwirth, Clare; Nicholson, Kirsty; Payne, Jules; Scott, James; Soran, Handrean; Walji, Shahenaz; Watkins, Suzanne; Weedon, Hazel; Nath Datta, Dev Borunendra

Pottle, Alison; Thompson, Gilbert; Barbir, Mahmoud; Bayly, Graham; Cegla, Jaimini; Cramb, Robert; Dawson, Tina; Eatough, Ruth; Kale, Vaishali; Neuwirth, Clare; Nicholson, Kirsty; Payne, Jules; Scott, James; Soran, Handrean; Walji, Shahenaz; Watkins, Suzanne; Weedon, Hazel; Nath Datta, Dev Borunendra.

Afiliação

Pottle A; Royal Brompton and Harefield NHS Foundation Trust, Harefield Hospital, London, United Kingdom.
Thompson G; Imperial College London, Hammersmith Hospital Campus, London, United Kingdom.
Barbir M; Royal Brompton and Harefield NHS Foundation Trust, Harefield Hospital, London, United Kingdom.
Bayly G; University Hospitals Bristol NHS Foundation Trust, Bristol Royal Infirmary, Bristol, United Kingdom.
Cegla J; Hammersmith Hospital Lipid Clinic, Imperial College Healthcare NHS Trust, London, United Kingdom.
Cramb R; University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom.
Dawson T; HEART UK The Cholesterol Charity, Maidenhead, United Kingdom.
Eatough R; Manchester University Trust, Manchester, United Kingdom.
Kale V; Royal Brompton and Harefield NHS Foundation Trust, Harefield Hospital, London, United Kingdom.
Neuwirth C; Hammersmith Hospital Lipid Clinic, Imperial College Healthcare NHS Trust, London, United Kingdom.
Nicholson K; Manchester University Trust, Manchester, United Kingdom.
Payne J; HEART UK The Cholesterol Charity, Maidenhead, United Kingdom.
Scott J; Hammersmith Hospital Lipid Clinic, Imperial College Healthcare NHS Trust, London, United Kingdom.
Soran H; Manchester University Trust, Manchester, United Kingdom.
Walji S; Hammersmith Hospital Lipid Clinic, Imperial College Healthcare NHS Trust, London, United Kingdom.
Watkins S; Lipid Unit, University Hospital Llandough, Penarth, Wales, United Kingdom.
Weedon H; Lipid Unit, University Hospital Llandough, Penarth, Wales, United Kingdom.
Nath Datta DB; Lipid Unit, University Hospital Llandough, Penarth, Wales, United Kingdom. Electronic address: dev.datta@wales.nhs.uk.

Atherosclerosis ; 290: 44-51, 2019 11.

Article em En | MEDLINE | ID: mdl-31563836

Assuntos

Remoção de Componentes Sanguíneos; Doenças Cardiovasculares/prevenção & controle; LDL-Colesterol/sangue; Hiperlipoproteinemia Tipo II/terapia; Lipoproteína(a)/sangue; Adolescente; Adulto; Idoso; Biomarcadores/sangue; Remoção de Componentes Sanguíneos/efeitos adversos; Doenças Cardiovasculares/epidemiologia; Criança; Pré-Escolar; Feminino; Predisposição Genética para Doença; Heterozigoto; Homozigoto; Humanos; Hiperlipoproteinemia Tipo II/sangue; Hiperlipoproteinemia Tipo II/epidemiologia; Hiperlipoproteinemia Tipo II/genética; Incidência; Lactente; Masculino; Pessoa de Meia-Idade; Sistema de Registros; Estudos Retrospectivos; Fatores de Risco; Fatores de Tempo; Resultado do Tratamento; Reino Unido/epidemiologia; Adulto Jovem

Palavras-chave

Cardiovascular events; Heterozygous familial hypercholesterolaemia; Homozygous familial hypercholesterolaemia; Lipoprotein (a); Lipoprotein apheresis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Remoção de Componentes Sanguíneos / Doenças Cardiovasculares / Lipoproteína(a) / Hiperlipoproteinemia Tipo II / LDL-Colesterol Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google